07:00 , Apr 30, 2012 |  BC Week In Review  |  Company News

anwerina, Riemser deal

Riemser acquired a 49% stake in anwerina for an undisclosed sum. anwerina focuses on metabolic bone diseases, cartilage replacement therapy and surgical treatment of vertebral compression fractures. Details were not disclosed. anwerina AG , Kreuzlingen,...